Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 3Prostatic Neoplasms 1Polyps 1Neoplasm, Residual 1Neoplasm Metastasis 1NSCLC 1Multiple Myeloma 1Mouth Neoplasms 1Breast Neoplasms 1Aggressive Periodontitis 1Adenomatous Polyps 1Adenoma 1

Interventions

Capecitabine 16Paclitaxel 12Docetaxel 10Cyclophosphamide 10Epirubicin 8Gemcitabine 7Letrozole 6Doxorubicin 6Carboplatin 6Trastuzumab 5Vinorelbine 4Cisplatin 4pertuzumab 3exemestane 3Neoadjuvant Therapy 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3130-nm albumin-bound paclitaxel 3apatinib 2Zoledronic Acid 2Thiotepa 2Taxes 2Tamoxifen 2Standard of Care 2Radiosurgery 2Melatonin 2Lapatinib 2Injections 2Goserelin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Neoplasms × Aspirin × Clear all
NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Centro Hospitalar Lisboa Ocidental

Phase 2/3 Unknown
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡